Renovacare Inc RCAR

Healthcare Biotechnology

RenovaCare, Inc. is a clinical-stage biotechnology company. The Company is focused on developing autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company through its wholly owned subsidiary, RenovaCare Sciences Corp. is focusing on the research, development and commercialization of autologous (using a patient’s own cells) cellular therapies that can be used for medical and aesthetic applications. The Company’s CellMist System is a cell isolation procedure that enzymatically renders stem cells from the patient’s own skin or other tissues. The resulting stem cell suspension is administered topically from the Company’s novel solution sprayer device (the SkinGun) as a cell therapy for wounds including burns to facilitate healing. Its SkinGun spray device is an advanced technology, using a gentle positive-pressure air stream to spray the CellMist Solution onto wounds.

GREY:RCAR - Post by User

Renovacare Inc > Buying

Bullboard Posts

Next >>

Post by Ferrari328on Feb 02, 2019 2:01pm

176 Views

Post# 29310284

Buying

RenovaCare Chairman Invests $15.5 Million to Fund SkinGun™ Regulatory Submissions and Clinical Trials.

When insider is adding money that a great sign to start build our position.
looks good, way oversold.
DD

Bullboard Posts

Next >>

Maximizing savings: Exploring 5 cash-back and promo deal apps